Acadian Asset Management
DNA icon

Acadian Asset Management’s Ginkgo Bioworks DNA Stock Holding History

Acadian Asset Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Buy
289,273
+243,102
+527% +$2.03M ﹤0.01% 972
2026
Q1 		$281K Buy
46,171
+11,472
+33% +$95.4K ﹤0.01% 1496
2025
Q4 		$285K Buy
34,699
+28,172
+432% +$303K ﹤0.01% 1446
2025
Q3 		$94K Buy
+6,527
New +$78.1K ﹤0.01% 1534
2025
Q2 		– Sell
-21,263
Closed -$120K – 1694
2025
Q1 		$120K Buy
+21,263
New +$217K ﹤0.01% 1325

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Acadian Asset Management's DNA Position: Q2 2026 in Review

Acadian Asset Management increased its Ginkgo Bioworks (DNA) stake by 527% in Q2 2026, buying an estimated $2.03M and bringing the position to 289,273 shares worth $2.86M. The position accounts for ﹤0.01% of the portfolio, ranked #972.

Acadian Asset Management first reported a position in DNA in Q1 2025 and has held it in 5 quarters since. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Acadian Asset Management held 289,273 shares of Ginkgo Bioworks worth $2.86M as of Q2 2026.
  • Acadian Asset Management bought 243,102 Ginkgo Bioworks shares in Q2 2026, an estimated $2.03M.
  • Ginkgo Bioworks made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #972 holding.
  • Acadian Asset Management first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 5 quarters since.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.